Literature DB >> 20403413

Identification of proteins regulated by estradiol in focal cerebral ischemic injury--a proteomics approach.

Jin-Hee Sung1, Eun-Hae Cho, Wongi Min, Mi-Jeong Kim, Myeong-Ok Kim, Eun-Jung Jung, Phil-Ok Koh.   

Abstract

Estradiol protects neuronal cells against permanent and focal ischemic brain damage. We identified the proteins that are expressed following estradiol administration during cerebral ischemia in an animal model. Adult female rats were ovariectomized and treated with oil or estradiol prior to middle cerebral artery occlusion (MCAO) to induce cerebral ischemia, and brains were collected 24h after MCAO. Protein analysis was performed on the cerebral cortex using two-dimensional gel electrophoresis. Protein spots with difference in intensity between oil- and estradiol-treated groups were identified by mass spectrometry. Among these proteins, levels of protein phosphatase 2A (PP2A) and astrocytic phosphoprotein PEA-15 were significantly decreased in the oil-treated group in comparison to the estradiol-treated group. Moreover, Western blot analysis demonstrated that estradiol treatment prevents injury-induced decrease of PP2A and PEA-15 levels during both MCAO-induced injury and glutamate exposure in HT22 cells. In contrast, levels of the 60kDa heat shock protein (Hsp 60) were significantly increased in oil-treated animals, while estradiol prevented the injury-induced increase of Hsp 60. The results of this study provide an evidence that estradiol protects neuronal cells against ischemic brain injury through the up- and down-modulation of specific proteins. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403413     DOI: 10.1016/j.neulet.2010.04.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Proteomic-Based Approaches for the Study of Ischemic Stroke.

Authors:  Haiying Li; Wanchun You; Xiang Li; Haitao Shen; Gang Chen
Journal:  Transl Stroke Res       Date:  2019-07-05       Impact factor: 6.829

Review 2.  Application of proteomics to cerebrovascular disease.

Authors:  Mingming Ning; Mary Lopez; Jing Cao; Ferdinando S Buonanno; Eng H Lo
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

3.  Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion.

Authors:  Fabio Di Domenico; Gabriella Casalena; Jia Jia; Rukhsana Sultana; Eugenio Barone; Jian Cai; William M Pierce; Chiara Cini; Cesare Mancuso; Marzia Perluigi; Catherine M Davis; Nabil J Alkayed; D Allan Butterfield; Allan D Butterfield
Journal:  J Neurochem       Date:  2012-03-28       Impact factor: 5.372

Review 4.  17β-estradiol and inflammation: implications for ischemic stroke.

Authors:  Ashley B Petrone; James W Simpkins; Taura L Barr
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

5.  Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.

Authors:  Trent M Woodruff; John Thundyil; Sung-Chun Tang; Christopher G Sobey; Stephen M Taylor; Thiruma V Arumugam
Journal:  Mol Neurodegener       Date:  2011-01-25       Impact factor: 14.195

Review 6.  Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.

Authors:  Karin Hochrainer; Wei Yang
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

7.  Proteomic analysis of primary cultured rat cortical neurons in chemical ischemia.

Authors:  Jung-Woo Seo; Younghoon Kim; Jinyoung Hur; Kang-Sik Park; Young-Wuk Cho
Journal:  Neurochem Res       Date:  2013-05-14       Impact factor: 3.996

8.  Estradiol attenuates down-regulation of PEA-15 and its two phosphorylated forms in ischemic brain injury.

Authors:  Phil-Ok Koh
Journal:  Lab Anim Res       Date:  2015-03-20

Review 9.  On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities.

Authors:  Yufeng Wei
Journal:  Pharmaceuticals (Basel)       Date:  2015-07-31

Review 10.  Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.

Authors:  Fiona H Greig; Graeme F Nixon
Journal:  Pharmacol Ther       Date:  2014-03-20       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.